PDS Biotechnology Corp (PDSB)
3.25
+0.02
(+0.46%)
USD |
NASDAQ |
Nov 05, 16:00
3.25
0.00 (0.00%)
After-Hours: 18:24
PDS Biotechnology Shareholders Equity (Quarterly): 30.92M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 30.92M |
| March 31, 2024 | 37.18M |
| December 31, 2023 | 26.13M |
| September 30, 2023 | 24.48M |
| June 30, 2023 | 32.44M |
| March 31, 2023 | 41.01M |
| December 31, 2022 | 44.00M |
| September 30, 2022 | 47.06M |
| June 30, 2022 | 51.43M |
| March 31, 2022 | 55.87M |
| December 31, 2021 | 63.21M |
| September 30, 2021 | 67.86M |
| June 30, 2021 | 72.99M |
| March 31, 2021 | 24.37M |
| December 31, 2020 | 27.13M |
| September 30, 2020 | 31.02M |
| June 30, 2020 | 17.01M |
| March 31, 2020 | 19.89M |
| December 31, 2019 | 11.70M |
| Date | Value |
|---|---|
| September 30, 2019 | 15.58M |
| June 30, 2019 | 20.61M |
| March 31, 2019 | 24.45M |
| December 31, 2018 | 29.84M |
| September 30, 2018 | 30.98M |
| June 30, 2018 | 33.34M |
| March 31, 2018 | 44.28M |
| December 31, 2017 | 62.37M |
| September 30, 2017 | 74.65M |
| June 30, 2017 | 84.27M |
| March 31, 2017 | 78.65M |
| December 31, 2016 | 89.28M |
| September 30, 2016 | 97.51M |
| June 30, 2016 | 106.76M |
| March 31, 2016 | 114.72M |
| December 31, 2015 | 122.48M |
| September 30, 2015 | -50.64M |
| June 30, 2015 | 52.14M |
| December 31, 2014 | -27.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.70M
Minimum
Dec 2019
72.99M
Maximum
Jun 2021
38.20M
Average
32.44M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Chimerix Inc | 155.58M |
| Cellectar Biosciences Inc | 12.38M |
| Marinus Pharmaceuticals Inc | -47.34M |
| Jaguar Health Inc | 16.91M |
| Seres Therapeutics Inc | -87.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.50M |
| Total Liabilities (Quarterly) | 29.58M |